Allergan (AGN) Tops Q4 EPS by 34c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Research and development: 288.5M
Today's EPS Names:
OMID, ACI, UNH, More
Financial Fact:
Research and development: 288.5M
Today's EPS Names:
OMID, ACI, UNH, More
Join SI Premium – FREE
Allergan (NYSE: AGN) reported Q4 EPS of $2.17, $0.34 better than the analyst estimate of $1.83. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $1.9 billion.
For earnings history and earnings-related data on Allergan (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UnitedHealth Group (UNH) Tops Q3 EPS by 57c, Beats on Revenue; Offers FY EPS Guidance
- Qualys (QLYS) PT Raised to $200 at TD Cowen
- Mizuho Upgrades Rexford Industrial Realty (REXR) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
